Revvity and Element Biosciences Collaborate to Advance Sequencing-based IVD Neonatal TestingBusiness Wire • 01/13/25
Revvity to Hold Earnings Call on Friday, January 31, 2025; Provides Update on Financial PerformanceBusiness Wire • 01/12/25
Despite Higher Valuations, Some Life Sciences Tools Stocks Create Good Opportunities: AnalystBenzinga • 12/13/24
Revvity Broadens Relationship with Genomics England to Advance Genomics in the UKBusiness Wire • 11/20/24
Scale Biosciences and Revvity's BioLegend Launch First-of-its-Kind Solution for High Parameter Protein Profiling of Single CellsBusiness Wire • 11/19/24
Revvity to Host Investor Day and Updates Organizational Structure to Reflect Recent TransformationBusiness Wire • 11/18/24
Revvity Introduces Transcribe AI: Revolutionizing Data Entry in Clinical LaboratoriesBusiness Wire • 10/22/24
Revvity Highlights its Strong Progress on Sustainability and Workplace Culture in 2024 Impact ReportBusiness Wire • 10/22/24
RVTY's Latest Launch to Enable APOE Genotyping of Alzheimer's DiseaseZacks Investment Research • 10/10/24